247 related articles for article (PubMed ID: 31481448)
1. Novel 5-Nitrofuran-Activating Reductase in Escherichia coli.
Le VVH; Davies IG; Moon CD; Wheeler D; Biggs PJ; Rakonjac J
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31481448
[TBL] [Abstract][Full Text] [Related]
2. Oxygen-insensitive nitroreductases: analysis of the roles of nfsA and nfsB in development of resistance to 5-nitrofuran derivatives in Escherichia coli.
Whiteway J; Koziarz P; Veall J; Sandhu N; Kumar P; Hoecher B; Lambert IB
J Bacteriol; 1998 Nov; 180(21):5529-39. PubMed ID: 9791100
[TBL] [Abstract][Full Text] [Related]
3. [Cross resistance of E. coli strains isolated from swine to nitrofuran compounds].
Borkowska-Opacka B; Truszczyński M
Med Dosw Mikrobiol; 1972; 24(1):1-7. PubMed ID: 4551588
[No Abstract] [Full Text] [Related]
4. An in vitro deletion in ribE encoding lumazine synthase contributes to nitrofurantoin resistance in Escherichia coli.
Vervoort J; Xavier BB; Stewardson A; Coenen S; Godycki-Cwirko M; Adriaenssens N; Kowalczyk A; Lammens C; Harbarth S; Goossens H; Malhotra-Kumar S
Antimicrob Agents Chemother; 2014 Dec; 58(12):7225-33. PubMed ID: 25246406
[TBL] [Abstract][Full Text] [Related]
5. Enzymes associated with reductive activation and action of nitazoxanide, nitrofurans, and metronidazole in Helicobacter pylori.
Sisson G; Goodwin A; Raudonikiene A; Hughes NJ; Mukhopadhyay AK; Berg DE; Hoffman PS
Antimicrob Agents Chemother; 2002 Jul; 46(7):2116-23. PubMed ID: 12069963
[TBL] [Abstract][Full Text] [Related]
6. Unravelling mechanisms of nitrofurantoin resistance and epidemiological characteristics among Escherichia coli clinical isolates.
Zhang X; Zhang Y; Wang F; Wang C; Chen L; Liu H; Lu H; Wen H; Zhou T
Int J Antimicrob Agents; 2018 Aug; 52(2):226-232. PubMed ID: 29753133
[TBL] [Abstract][Full Text] [Related]
7. Development and analysis of furazolidone-resistant Escherichia coli mutants.
Martínez-Puchol S; Gomes C; Pons MJ; Ruiz-Roldán L; Torrents de la Peña A; Ochoa TJ; Ruiz J
APMIS; 2015 Aug; 123(8):676-81. PubMed ID: 26011027
[TBL] [Abstract][Full Text] [Related]
8. In vitro synergy between sodium deoxycholate and furazolidone against enterobacteria.
Le VVH; Olivera C; Spagnuolo J; Davies IG; Rakonjac J
BMC Microbiol; 2020 Jan; 20(1):5. PubMed ID: 31906851
[TBL] [Abstract][Full Text] [Related]
9. [Susceptibility of E. coli strains to nitrofurans with special reference to acquiring resistance in vitro].
Borkowska-Opacka B; Truszczyński M
Pol Arch Weter; 1972; 15(4):679-88. PubMed ID: 4576321
[No Abstract] [Full Text] [Related]
10. Action of some nitrofuran derivatives on glucose metabolism, ATP levels, and macromolecule synthesis in Escherichia coli.
Lu C; McCalla DR
Can J Microbiol; 1978 Jun; 24(6):650-7. PubMed ID: 352498
[No Abstract] [Full Text] [Related]
11. [Infection resistance of Escherichia coli isolated from feces of healthy subjects to nitrofuran preparations].
Shenderov BA; Ob'edkova LM; Grigor'eva IV
Zh Mikrobiol Epidemiol Immunobiol; 1972 Feb; 49(2):52-8. PubMed ID: 4554797
[No Abstract] [Full Text] [Related]
12. Comparative in vitro activity of five nitrofurans.
Hamilton-Miller JM; Brumfitt W
Chemotherapy; 1978; 24(3):161-5. PubMed ID: 657876
[TBL] [Abstract][Full Text] [Related]
13. The structures of E. coli NfsA bound to the antibiotic nitrofurantoin; to 1,4-benzoquinone and to FMN.
Day MA; Jarrom D; Christofferson AJ; Graziano AE; Anderson JLR; Searle PF; Hyde EI; White SA
Biochem J; 2021 Jul; 478(13):2601-2617. PubMed ID: 34142705
[TBL] [Abstract][Full Text] [Related]
14. E. coli NfsA: an alternative nitroreductase for prodrug activation gene therapy in combination with CB1954.
Vass SO; Jarrom D; Wilson WR; Hyde EI; Searle PF
Br J Cancer; 2009 Jun; 100(12):1903-11. PubMed ID: 19455141
[TBL] [Abstract][Full Text] [Related]
15. Oxygen-insensitive nitroreductase E. coli NfsA, but not NfsB, is inhibited by fumarate.
Day MA; Jarrom D; Rajah N; Searle PF; Hyde EI; White SA
Proteins; 2023 May; 91(5):585-592. PubMed ID: 36443029
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of nitrofuran resistance in Salmonella enteritidis phage type 4 and interpretation of nitrofuran susceptibility tests.
Brown DF; Upson R; Brenwald NP; Rampling A
J Antimicrob Chemother; 1991 Jan; 27(1):23-8. PubMed ID: 2050594
[TBL] [Abstract][Full Text] [Related]
17. [Sensitivity of Proteus to some antibiotics and nitrofuran preparations].
Lukach IG; Maiko II
Antibiotiki; 1968 Feb; 13(2):162-4. PubMed ID: 4875641
[No Abstract] [Full Text] [Related]
18. Plasmid-Mediated OqxAB Is an Important Mechanism for Nitrofurantoin Resistance in Escherichia coli.
Ho PL; Ng KY; Lo WU; Law PY; Lai EL; Wang Y; Chow KH
Antimicrob Agents Chemother; 2016 Jan; 60(1):537-43. PubMed ID: 26552976
[TBL] [Abstract][Full Text] [Related]
19. Flavin oxidation state impacts on nitrofuran antibiotic binding orientation in nitroreductases.
Toogood HS; Scrutton NS
Biochem J; 2021 Sep; 478(18):3423-3428. PubMed ID: 34554213
[TBL] [Abstract][Full Text] [Related]
20. Incidence and Genetic Bases of Nitrofurantoin Resistance in Clinical Isolates of Two Successful Multidrug-Resistant Clones of Salmonella enterica Serovar Typhimurium: Pandemic "DT 104" and pUO-StVR2.
García V; Montero I; Bances M; Rodicio R; Rodicio MR
Microb Drug Resist; 2017 Jun; 23(4):405-412. PubMed ID: 27809653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
